Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Exact Sciences Cor (NQ: EXAS )

60.54 +0.53 (+0.88%)
Official Closing Price Updated: 4:15 PM EDT, May 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 1,587,056
Open 60.53
Bid (Size) 60.00 (1)
Ask (Size) 61.20 (1)
Prev. Close 60.01
Today's Range 59.13 - 61.18
52wk Range 56.05 - 100.77
Shares Outstanding 171,948,769
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Exact Sciences to Participate in May Investor Conference
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
From Exact Sciences Corp.
Via Business Wire

Performance

YTD
-17.93%
-17.93%
1 Month
-17.90%
-17.90%
3 Month
-5.30%
-5.30%
6 Month
-3.07%
-3.07%
1 Year
-4.95%
-4.95%

More News

Read More
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
From Exact Sciences Corp.
Via Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
(EXAS) - Analyzing Exact Sciences's Short Interest
Via Benzinga
2 Beaten-Down Cathie Wood Stocks With Massive Potential
Via The Motley Fool
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
From Exact Sciences Corp.
Via Business Wire
Exact Sciences Schedules First Quarter 2024 Earnings Call
From Exact Sciences Corp.
Via Business Wire
The 3 Best Cathie Wood Stocks to Buy in April 2024
Via InvestorPlace
1 Beaten-Down Cathie Wood Stock to Buy and Hold
Via The Motley Fool
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
From Exact Sciences Corp.
Via Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
Via Investor's Business Daily
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Topics Stocks
Exposures US Equities
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
Via Benzinga
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
From Exact Sciences Corp.
Via Business Wire
3 Biotech Stocks to Buy on the Dip: March 2024
Via InvestorPlace
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
From Exact Sciences Corp.
Via Business Wire
3 Growth Stocks to Buy at 52-Week Lows in March
Via InvestorPlace
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
From Exact Sciences Corp.
Via Business Wire
Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms
Via Investor's Business Daily
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
Via Talk Markets
Exact Sciences and Basketball Great Jamal Mashburn Encourage Americans 45+ to Have a Game Plan Against Colon Cancer
From Exact Sciences Corp.
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
The Top 3 Healthcare Stocks to Buy on Weakness in 2024
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.